Browsing tag

infant milk formula

Precision Fermentation Breast Milk Startup Helaina Bags $20M Series A

2 Mins Read Helaina, the startup developing immune-equivalent proteins in breast milk through precision fermentation, has raised $20 million. Helaina has closed its Series A funding round with $20 million, co-led by early-stage tech investors Spark Capital and Siam Capital. Participating investors included Primary Venture Partners and Plum Alley Investments, as well as American celebrities like Tom Williams, […]

Singapore-Based TurtleTree Announces Cell-Based Human Lactoferrin As First Commercial Product

4 Mins Read Singapore and U.S.-based food tech TurtleTree will be launching human lactoferrin as its first cell-based commercial product. Until now, lactoferrin has been derived from cow’s milk and is used in infant milk formulas for its immunity-boosting properties, as well as in performance nutrition and medical applications. TurtleTree is now gearing up to bring to market […]

Is Nestlé Gearing Up To Enter The Cell-Based Infant Milk Space?

3 Mins Read Swiss food giant Nestlé has posted a new opening for a specialist in mammary gland development and lactation biology, signalling that it could be preparing its entry into the cell-cultured infant milk sector. While still in its early stages, the cultivated dairy and breast milk industry could cause serious disruption to the soon-to-be US$103 billion […]

Sprout Organic To Launch 100% Plant-Based Organic Infant Formula At Trade Shows In Australia To Scale Distribution

3 Mins Read Sprout Organic, which develops and produces plant-based nutritional products for children, is now taking pre-sale orders and is set to launch its plant-based organic infant formula at two trade shows – the Australian Pharmacy Professional Conference and the Naturally Good Expo, in an effort to enter the formula sales channels in the Pacific country. Though […]

108Labs To Launch Cell-Based ‘Whole-Human Infant Formula’ With Antibodies Against Pathogens

3 Mins Read Cellular agriculture biotech 108Labs is developing “whole-human infant formula” that contains the biosimilar secretory antimicrobial antibodies from mother’s milk. The discovery, made during the development of its patent-pending Colostrupedics formula, could provide newborns with protection against gastrointestinal pathogens, putting 108Labs’ cell-based solution at the forefront of disrupting the infant nutrition market.  108Labs, the U.S.-based biotech […]